Skip to main content

Table 2 System suitability results

From: Determination of enantiomer impurity in Bortezomib lyo injection formulation by using normal-phase liquid chromatography

Component name

Retention time (min)

Relative retention time (RRT)

Resolution

Tailing factor

Theoretical plates

(1S,2R-enantiomer) impurity

10.57

0.59

4.20

1.36

1784

Bortezomib

17.98

1.00

1.54

891